<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: Genezen  and Optieum Biotechnologies Partner to Support cGMP Manufacturing of Groundbreaking CAR-T Therapy for Glioblastoma	</title>
	<atom:link href="https://optieumbio.com/genezen-and-optieum-biotechnologies-partner-to-support-cgmp-manufacturing-of-groundbreaking-car-t-therapy-for-glioblastoma/feed/" rel="self" type="application/rss+xml" />
	<link>https://optieumbio.com/genezen-and-optieum-biotechnologies-partner-to-support-cgmp-manufacturing-of-groundbreaking-car-t-therapy-for-glioblastoma/</link>
	<description></description>
	<lastBuildDate>Tue, 06 May 2025 03:03:29 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	
</channel>
</rss>
